First Time Loading...

MaxCyte Inc
LSE:MXCT

Watchlist Manager
MaxCyte Inc Logo
MaxCyte Inc
LSE:MXCT
Watchlist
Price: 297 GBX Market Closed
Updated: May 5, 2024

MaxCyte Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MaxCyte Inc
Revenue Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
MaxCyte Inc
LSE:MXCT
Revenue
$41.3m
CAGR 3-Years
16%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Revenue
$42.9B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
13%
Danaher Corp
NYSE:DHR
Revenue
$43.7B
CAGR 3-Years
21%
CAGR 5-Years
21%
CAGR 10-Years
9%
Mettler-Toledo International Inc
NYSE:MTD
Revenue
$3.8B
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
5%
Agilent Technologies Inc
NYSE:A
Revenue
$6.7B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
8%
IQVIA Holdings Inc
NYSE:IQV
Revenue
$15B
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
11%

See Also

What is MaxCyte Inc's Revenue?
Revenue
41.3m USD

Based on the financial report for Dec 31, 2023, MaxCyte Inc's Revenue amounts to 41.3m USD.

What is MaxCyte Inc's Revenue growth rate?
Revenue CAGR 5Y
20%

Over the last year, the Revenue growth was -7%. The average annual Revenue growth rates for MaxCyte Inc have been 16% over the past three years , 20% over the past five years .